VivoSim Labs, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
VivoSim Labs, Inc. (VIVS) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $61.20 thousand for the 24-month period ending 2011-12-31, per its 10-Q filed 2012-01-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2012-01-17
- VivoSim Labs, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-12-31 was $32.33K, a 2369.82% increase year-over-year.
- VivoSim Labs, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-09-30 was $18.18K, a 746.58% increase year-over-year.
- VivoSim Labs, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2010-12-31 was $1.31K.
- VivoSim Labs, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2010-09-30 was $2.15K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 21 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 24 month |
|---|---|---|---|---|
| 2011-12-31 | $32.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-17 | $50.51K 10-Q · filed 2012-01-17 | $61.20K 10-Q · filed 2012-01-17 | |
| 2011-09-30 | $18.18K 10-Q · filed 2011-10-31 | $28.87K 10-Q · filed 2011-10-31 | ||
| 2010-12-31 | $1.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-17 | $3.46K 10-Q · filed 2012-01-17 | ||
| 2010-09-30 | $2.15K 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |